| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 2635 |
| 1 | PREDNISONE | 640 |
| 2 | VEDOLIZUMAB | 633 |
| 3 | INFLIXIMAB | 543 |
| 4 | METHOTREXATE SODIUM | 487 |
| 5 | METHOTREXATE | 448 |
| 6 | AZATHIOPRINE | 394 |
| 7 | OMEPRAZOLE MAGNESIUM | 273 |
| 8 | PANTOPRAZOLE | 251 |
| 9 | ACETAMINOPHEN | 240 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LEVAMLODIPINE | 5 | 0.0400 |
| 1 | DIMETHYL SULFOXIDE | 6 | 0.0247 |
| 2 | USTEKINUMAB-STBA | 5 | 0.0135 |
| 3 | ADALIMUMAB-RYVK | 13 | 0.0119 |
| 4 | VEDOLIZUMAB | 633 | 0.0073 |
| 5 | MEFENAMIC ACID | 13 | 0.0059 |
| 6 | BALSALAZIDE DISODIUM | 3 | 0.0058 |
| 7 | MELPHALAN HYDROCHLORIDE | 139 | 0.0055 |
| 8 | BEPOTASTINE BESILATE | 3 | 0.0047 |
| 9 | DINUTUXIMAB | 4 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1226 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 717 |
| 2 | Integrin Receptor Antagonist [EPC] | 633 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 582 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 465 |
| 5 | Purine Antimetabolite [EPC] | 398 |
| 6 | Proton Pump Inhibitor [EPC] | 370 |
| 7 | Vitamin C [EPC] | 337 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 278 |
| 9 | Vitamin B12 [EPC] | 278 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Integrin Receptor Antagonist [EPC] | 633 | 0.0073 |
| 1 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 2 | Antidiarrheal [EPC] | 1 | 0.0042 |
| 3 | Purine Antimetabolite [EPC] | 398 | 0.0040 |
| 4 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 4 | 0.0037 |
| 5 | Non-Standardized Pollen Allergenic Extract [EPC] | 2 | 0.0032 |
| 6 | Standardized Pollen Allergenic Extract [EPC] | 2 | 0.0031 |
| 7 | GLP-2 Analog [EPC] | 37 | 0.0028 |
| 8 | Non-Standardized House Dust Allergenic Extract [EPC] | 2 | 0.0027 |
| 9 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |